{
  "pmcid": "11920631",
  "sha256": "4ffe679d10295721ce2d7dd6b575c20fdfc226afdfa661dbb15102abd3503034",
  "timestamp_utc": "2025-11-09T23:22:59.291877+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.171727646253181,
    "reading_ease": 33.01417922128746,
    "word_count": 269
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Opioid-Sparing Anesthesia in Laparoscopic Major Abdominal Surgery"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "double-blind, randomised controlled trial was conducted at a single center from May 2022 to August 2023"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were adults aged 18-65 years undergoing laparoscopic major abdominal surgery"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to receive either remifentanil (Remi group, n=77) or esketamine combined with dexmedetomidine (OS group, n=80)"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the numeric rating scale (NRS) pain score on postoperative day (POD)1"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated list, and allocation was concealed with opaque envelopes"
      },
      "Blinding": {
        "score": 3,
        "evidence": "Patients, clinicians, and outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Remi group, n=77 or esketamine combined with dexmedetomidine (OS group, n=80)"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis was conducted on 157 patients using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "OS group had significantly lower NRS pain scores and a lower proportion of rescue analgesia compared to the Remi group (NRS: 1 vs 3, p=0.001; rescue analgesia: 5.0% vs 15.6%, p=0.028)"
      },
      "Harms": {
        "score": 1,
        "evidence": "proportion of dreaminess was higher (42.5% vs 15.6%, p<0.01)"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial Registration: ChiCTR2200060130"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}